Clinical Evaluation of Dapagliflozin in the Management of CKD: Focus on Patient Selection and Clinical Perspectives-Reference-Cited by-同舟云学术

Clinical Evaluation of Dapagliflozin in the Management of CKD: Focus on Patient Selection and Clinical Perspectives

Published:2022-11 Issue: Volume:Volume 15 Page:289-308
ISSN:1178-7058
Container-title:International Journal of Nephrology and Renovascular Disease
language:en
Short-container-title:IJNRD

Author:

Nashar Khaled,Khalil Patricia

Publisher

Informa UK Limited

Subject

Nephrology

Reference80 articles.

1. Kidney Disease: Improving Global Outcomes CKD Working Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.

2. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010

3. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

4. Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2021. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2021.

5. Recognition and Management of Chronic Kidney Disease in an Elderly Ambulatory Population

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Emerging clinical approaches in diabetic cardiomyopathy: insights from clinical trials and future directions”;Acta Diabetologica;2024-09-10

2. Terpenes in the management of chronic kidney disease;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-04-29

3. SGLT-2 Inhibitors: Focus on Dapagliflozin;Cardiology in Review;2024-04-26

4. Effect of Drugs Used in Pharmacotherapy of Type 2 Diabetes on Bone Density and Risk of Bone Fractures;Medicina;2024-02-26

5. Results of the DAPA-CKD trial and their impact on clinical practice;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2023-07-18